Signal transduction in cellular senescence

Journal of the American Geriatrics Society

Volumn 45, Issue 3, 1997, Pages 361-366

  Obeid, Lina M ^a   Venable, Mark E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b APPALACHIAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; GLYCEROLIPID; PHOSPHOLIPASE D; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN C FOS; PROTEIN KINASE C; PROTEINASE; RETINOBLASTOMA PROTEIN; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTOR AP 1;

AGED; CELL AGING; ENZYME MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION;

EID: 0031049462     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb00954.x     Document Type: Review

References (56)

1. Hayflick L, Moorhead PS. The serial cultivation of human diploid strains. Exp Cell Res 1961;25:585-621.
2. Goldstein S. Replicative senescence: The human fibroblast comes of age. Science 1990;249:1129-1133.
3. Norwood TH., Pendergrass WR, Sprague CA, Martin GM. Dominance of the senescent phenotype in heterokaryons between replicative and post-replicative human fibroblast-like cells. Proc Natl Acad Sci USA 1974;71:2231-2235.
4. Pereira-Smith OM, Smith JR. Phenotype of low proliferative potential is dominant in hybrids of normal human fibroblasts. Somatic Cell Genet 1982;8:731-742.
5. Lumpkin CK, McClung JK, Pereira-Smith OM, Smith JR. Existence of high abundance antiproliferative mRNA's in senescent human diploid fibroblasts. Science 1986;232:393-398.
6. Gorman SD, Cristofalo VJ. Reinitiation of cellular DNA synthesis in BrdU-selected nondividing senescent WI-38 cells by simian virus 40 infection. J Cell Physiol 1985;125:122-126.
7. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence: Implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989;9:3088-3092.
8. Bell E, Marek LF, Levinstone DS et al. Loss of division potential in vitro: Aging or differentiation? Science 1978;202:1158-1163.
9. Martin G, Sprague CA, TH Norwood, Pendergrass WR. Clonal selection, attenuation and differentiation in an vitro model of hyperplasia. Am J Pathol 1974;74:137-154.
10. Harley CB, Goldstein S. Intraclonal variation in proliferative potential of human diploid fibroblasts: Stochastic mechanism for cellular aging. Science 1980;207:82-83.
11. Exton JH. Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta 1994;1212:26-42.
12. Liscovitch M. Signal-dependent activation of phosphatidylcholine hydrolysis: Role of phospholipase D. Biochem Soc Trans 1991;19:402-408.
13. Venable ME, Globe GC, Obeid EM. Identification Of a defect in the phospholipase D/diacylglycerol pathway in cellular senescence. J Biol Chem 1994;269:26040-26044.
14. Chang ZF, Huang DY. Decline of protein kinase C activation in response to growth stimulation during senescence of IMR-90 human diploid fibroblasts. Biochem Biophys Res Commun 1994;200:16-27.
15. Angel P, Imagawa M, Chiu R et al. Phorbol ester-inducible genes contain a common cis element recognized by TPA-modulated transacting factor. Cell 1987;49:729-739.
16. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992;70:375-387.
17. Hannun YA. The Sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994;269:3125-3238.
18. Hannun YA, Loomis CR, Merrill AH Jr, Bell RM. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and human platelets. J Biol Chem 1986;261:12604-12609.
19. 3 in HL-60 cells. Role in cell differentiation. J Biol Chem 1989;264:19076-19080.
20. Obeid EM, Linardic CM, LA Karolak Hannun YA. Programmed cell death induced by ceramide. Science 1993;259:1769-1771.
21. Kim M-Y, Linardic C, Obeid LM, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and gamma-interferon. Specific role in cell differentiation. J Biol Chem 1991;266:484-489.
22. Tepper CG, Jayadev S, Liu B et al. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 1995;92:8443-8447.
23. 2 production and sphingomyelin metabolism. Evidence for the regulation of cyclo-oxygenase gene expression by sphingosine and ceramide. J Biol Chem 1992;267:20044-20050.
24. Dobrowsky RT, Werner MH, Castellino AM et al. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265:1994;1596-1599.
25. Niculescu F, Rus H, Shin S et al. Generation of diacylglycerol and ceramide during homologous complement activation. J Immunol 1993;150:214-224.
26. 3-induced HL-60 cell differentiation. J Biol Chem 1990;265:15823-15831.
27. Jayadev S, Liu B, Bielawska AE et al. Role for ceramide in cell cycle arrest. J Biol Chem 1995; 270:2047-2052.
28. Venable ME, Lee JY, Smyth MJ et al. Role of ceramide in cellular senescence. J Biol Chem 1995;270:30701-30708.
29. Dbaibo GS, Pushkareva MY, Jayadev S et al. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci USA 1995;92:1347-1351.
30. Venable ME, Obeid LM. Ceramide inhibits protein kinase C activation of G-protein-dependent phospholipase D in vitro. J Biol Chem 1995;270:30701-30708.
31. Nakamura TA, Abe KJ, Balazovich D et al. Ceramide regulates oxidant release in adherent human neutrophils. J Biol Chem 1994;269:18384-18389.
32. Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 1993;268:15523-15530.
33. Wolff RA, Dobrowsky RT, Bielawska A et al. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem 1994; 269: 19605-19609.
34. Afshari CA, Barrett JC. Disruption of Go/G1 arrest in quiescent and senescent cells treated with phosphatase inhibitors. Cancer Res 1994;54:2317-2321.
35. Smyth MJ, Perry DK, Zhang J et al. prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of bcl-2. Biochem J 1996, 316:25-28.
36. de Murcia G, Schreiber V, Molinete M et al. Structure and function of poly(ADP-ribose) polymerase. Mol Cell Biochem 1994; 138:15-24.
37. Dell'orco RT, Anderson LE. Decline of poly(ADP-ribosyl)ation during in vitro senescence in human diploid fibroblasts. J Cell Physiol 1991;146:216-221.
38. Spence MW. Spingomyelinases. Lipid Res 1993; 26:3-23.
39. 3-induced HL-60 cell differentiation. 1994;J Biol Chem 269:4070-4077.
40. Vojta PJ, Barrett JC. Genetic analysis of cellular senescence. Biochim Biophys Acta 1995;1242:29-41.
41. Seshadri T, Campisi J. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 1990;247:205-209.
42. Riabowol K, Schiff J, Gilman MZ. Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc Natl Acad Sci USA 1992;89:157-161.
43. Lee W-H, Bookstein R, Hong F et al. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 1987;235:1394-1399.
44. Chen P-L, Scully P, Shew J-Y et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989;58:1193-1198.
45. Flemington EK, Speck SH, Kaelin WG Jr. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 1993;90:6914-6918.
46. Goodrich DW, Wang NP, Qian Y-W et al. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991;67:293-302.
47. Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 1990;249:666-669.
48. Tang Z, Zhang Z, Zheng Y et al. Cell aging of human diploid fibroblasts is associated with changes in responsiveness to epidermal growth factor and changes in HER-2 expression. Mech Aging Dev 1994;73:57-67.
49. Aoyagi M, Fukai N, Ogami K et al. Kinetics of 125I-PDGF binding and downregulation of PDGF receptor in human arterial smooth muscle cell strains during cellular senescence in vitro. J Cell Physiol 1995;164:376-384.
50. Mori S, Kawano M, Kenzaki T et al. Decreased expression of the platelet-derived growth factor receptor in fibroblasts from a patient with Werner's syndrome. Eur J Clin Invest 1996;23:161-165.
51. Ferber A, Chang C, Sell C et al. Failure of senescent human fibroblasts to express the insulin-like growth factor-1 gene. J Biol Chem 1993;268:17883-17888.
52. Sell C, Ptasznik A, Chang C-D et al. IGF-1 receptor levels and the proliferation of young and senescent human fibroblasts. Biochem Biophys Res Commun 1993;194:259-265.
53. Delgado D, Raymond L, Dean R. C-ras expression decreases during in vitro senescence in human fibroblasts. Biochem Biophys Res Commun 1986;137:917-921.
54. Medrano EE, Yang F, Boissy R et al. Terminal differentiation and senescence in the human melanocyte: repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines two phenotypes. Mol Biol Cell 1994;5:497-509.
55. Afshari CA, Vojta PJ, Annab LA et al. Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp Cell Res 1993;209:231-237.
56. Choudhury GG, Sylvia VL, Sakagushi AY. Decline of signal transduction by phospholipase C gamma 1 in IMR 90 human diploid fibroblasts at high population doubling levels. FEBS Lett 1991;293:211-214.